A vaccine for respiratory syncytial virus (RSV) is now available for older Canadians, but experts worry that cost of the vaccine could be a barrier to seniors and could lead to preventable hospitalizations — and potentially, death.
Health
Cost of RSV vaccine a barrier to older Canadians amid respiratory season, experts warn
More Videos
-
Why hot, humid weather extremes are causing growing health risks
-
Health Matters: Researchers identify genetic obesity trigger
-
Renters may face higher risk of death in extreme heat: study
-
Health Matters: Students sweltering in Ontario, Quebec as many schools are without air conditioning
-
Tainted liquor kills over 31 in India’s Tamil Nadu area
-
Deaths in Canada increase on days of extreme heat: StatCan
You are viewing an Accelerated Mobile Webpage.
View Original Article